Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal
- 15 September 2003
- journal article
- research article
- Published by Elsevier BV in Behavioural Brain Research
- Vol. 144 (1-2), 25-35
- https://doi.org/10.1016/s0166-4328(03)00044-5
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male miceBehavioural Brain Research, 2001
- NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticityBrain Research Reviews, 1999
- Under Siege: The Brain on OpiatesNeuron, 1996
- The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal Medication Development Issues for Opiate AddictionNeuropsychopharmacology, 1995
- The role of dopamine in drug abuse viewed from the perspective of its role in motivationDrug and Alcohol Dependence, 1995
- Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent miceEuropean Neuropsychopharmacology, 1993
- The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawalLife Sciences, 1992
- Mode of binding of [3H]dibenzocycloalkenimine (MK‐801) to the N‐methyl‐D‐aspartate (NMDA) receptor and its therapeutic implicationFEBS Letters, 1988
- Heroin reward is dependent on a dopaminergic substrateLife Sciences, 1981
- Supersensitivity of cortical neurones of the rat to acetylcholine and L-glutamate following chronic morphine treatmentNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976